KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Treasury Shares (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Treasury Shares for 11 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 1.22% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, up 1.22% year-over-year, with the annual reading at $2.2 million for FY2025, 1.22% up from the prior year.
  • Treasury Shares hit $2.2 million in Q4 2025 for Fulgent Genetics, up from $600000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.6 million in Q4 2022 to a low of $10000.0 in Q1 2024.
  • Historically, Treasury Shares has averaged $961785.7 across 5 years, with a median of $534500.0 in 2025.
  • Biggest five-year swings in Treasury Shares: tumbled 91.96% in 2023 and later surged 5900.0% in 2025.
  • Year by year, Treasury Shares stood at $1.6 million in 2021, then skyrocketed by 62.51% to $2.6 million in 2022, then dropped by 16.0% to $2.2 million in 2023, then decreased by 0.18% to $2.2 million in 2024, then rose by 1.22% to $2.2 million in 2025.
  • Business Quant data shows Treasury Shares for FLGT at $2.2 million in Q4 2025, $600000.0 in Q3 2025, and $177000.0 in Q2 2025.